Neuropeptide Y phase advances the in vitro hamster circadian clock during the subjective day with no effect on phase during the subjective night

Canadian Journal of Physiology and Pharmacology

Volumn 78, Issue 2, 2000, Pages 87-92

  Harrington, Mary E ^a   Schak, Kathryn M ^a  

^a SMITH COLLEGE   (United States)

Author keywords

Circadian; Neuropeptide Y; Rhythm; Suprachiasmatic

Indexed keywords

NEUROPEPTIDE Y;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CIRCADIAN RHYTHM; CONTROLLED STUDY; ELECTROPHYSIOLOGY; HAMSTER; HYPOTHALAMUS; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SUPRACHIASMATIC NUCLEUS;

EID: 0034097202     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y99-130     Document Type: Article

References (56)

1. Albers, H.E., and Ferris, C.F. 1984. Neuropeptide Y: role in light-dark cycle entrainment of hamster circadian rhythms. Neurosci. Lett. 50: 163-168.
2. Allen, C.N., Jiang, Z.G., Teshima, K., Darland, T., Ikeda, M., Nelson, C.S., Quigley, D.I., Yoshioka, T., Allen, R.G., Rea, M.A., and Grandy, D.K. 1999. Orphanin-FQ/nociceptin (OFQJN) modulates the activity of suprachiasmatic nucleus neurons. J. Neurosci. 19: 2152-2160.
3. Baraban, S.C. 1998. Neuropeptide Y and limbic seizures. Rev. Neurosci. 9: 117-128.
4. Biello, S.M., and Mrosovsky, N.M. 1996. Phase response curves to neuropeptide Y in wildtype and tau mutant hamsters. J. Biol. Rhythms, 11: 27-34.
5. Biello, S.M., Janik, D., and Mrosovsky, N. 1994. Neuropeptide Y and behaviorally induced phase shifts. Neuroscience, 62: 273-279.
6. Biello, S.M., Golombek, D., and Harrington, M.E. 1997a. Neuropeptide Y and glutamate block each other's phase shifts in the suprachiasmatic nucleus in vitro. Neuroscience, 77: 1049-1057.
7. Biello, S.M., Golombek, D.A., Schak, K.M., and Harrington, M.E. 1997b. Circadian phase shifts to neuropeptide Y in vitro: cellular communication and signal transduction. J. Neurosci. 17: 8468-8475.
8. Challet, E., Pevet, P., and Malan, A. 1996. Intergeniculate leaflet lesion and daily rhythms in food-restricted rats fed during daytime. Neurosci. Lett. 216: 214-218.
9. Challet, E., Scarbrough, K., Penev, P.D., and Turek, F.W. 1998. Roles of suprachiasmatic nuclei and intergeniculate leaflets in mediating the phase-shifting effects of a serotonergic agonist and their photic modulation during subjective day. J. Biol. Rhythms, 13: 410-421.
10. Chevassus-au-Louis, N., and Cooper, H.M. 1998. Is there a geniculohypothalamic tract in primates? A comparative immunohistochemical study in the circadian system of strepsirhine and haplorhine species. Brain Res. 805: 213-219.
11. Cohen, R.A., and Albers, H.E. 1991. Disruption of human circadian and cognitive regulation following a discrete hypothalamic lesion: a case study. Neurology, 41: 726-729.
12. Cote, N.K., and Harrington M.E. 1993. Histamine phase shifts the circadian clock in a manner similar to light. Brain Res. 613: 149-151.
13. Cutler, D.J., Piggins, H.D., Selbie, L.A., and Mason, R. 1998. Responses to neuropeptide Y in adult hamster suprachiasmatic nucleus neurones in vitro. Eur. J. Pharmacol. 345: 155-162.
14. Earnest, D.J., and Turek, F.W. 1985. Neurochemical basis for the photic control of circadian rhythms and seasonal reproductive cycles: role for acetylcholine. Proc. Natl. Acad. Sci. U.S.A. 82: 4277-4281.
15. Ebling, F.J. 1996. The role of glutamate in the photic regulation of the suprachiasmatic nucleus. Prog. Neurobiol. 50: 109-132.
16. Edelstein, K., and Amir, S. 1999. The intergeniculate leaflet does not mediate the disruptive effects of constant light on circadian rhythms in the rat. Neuroscience, 90: 1093-1101.
17. Edgar, D.M., Dement, W.C., and Fuller, C.A. 1993a. Effect of SCN lesions on sleep in squirrel monkeys: evidence for opponent processes in sleep-wake regulation. J. Neurosci. 13: 1065-1079.
18. Edgar, D.M., Miller, J.D., Prosser, R.A., Dean, R.R., and Dement, W.C. 1993b. Serotonin and the mammalian circadian system. II. Phase-shifting rat behavioral rhythms with serotonergic agonists. J. Biol. Rhythms, 8: 17-31.
19. Golombek, D.A., Biello, S.M., Rendon, R.A., and Harrington, M.E. 1996. Neuropeptide Y phase shifts the circadian clock in vitro via a Y2 receptor. Neuroreport, 7: 1315-1319.
20. Gribkoff, V.K., Pieschl, R.L., Wisialowski, T.A., Van Den Pol, A.N., and Yocca, F.D. 1998. Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes. J. Neurosci. 18: 3014-3022.
21. Hall, A.C., Earle-Cruickshanks, G., and Harrington, M.E. 1999. Role of membrane conductances and protein synthesis in subjective day phase advances of the hamster circadian clock by neuropeptide Y. Eur. J. Neurosci. 11: 3424-3432.
22. Hannibal, J., Ding, J.M., Chen, D., Fahrenkrug, J., Larsen, P.J., Gillette, M.U., and Mikkelsen, J.D. 1997. Pituitary adenylate cyclase-activating peptide (PACAP) in the retinohypothalamic tract: a potential daytime regulator of the biological clock. J. Neurosci. 17: 2637-2644.
23. Harrington, M.E. 1997. The ventral lateral geniculate nucleus and the intergeniculate leaflet: interrelated structures in the visual and circadian systems. Neurosci. Biobehav. Rev. 21: 705-727.
24. Harrington, M.E., and Hoque, S. 1997. NPY opposes PACAP phase shifts via receptors different from those involved in NPY phase shifts. Neuroreport, 8: 2677-2680.
25. Harrington, M.E., and Mistlberger, R. 2000. Anatomy and physiology of the mammalian circadian system. In Principles and practice of sleep medicine. 3rd ed. Edited by M.H. Kryger, T. Roth, and W.C. Dement. W.B. Saunders, Philadelphia. In press.
26. Harrington, M.E., Hoque, S., Hall, A.C., Golombek, D.A., and Biello, S.M. 1999. Pituitary adenylate cyclase activating peptide (PACAP) phase shifts circadian rhythms in a manner similar to light via potentiation of NMDA currents. J. Neurosci. 19: 6637-6642.
27. Hokfelt, T., Broberger, C., Zhang, X., Diez, M., Kopp, J., Xu, Z., Landry, M., Bao, L., Schalling, M., Koistinaho, J., DeArmond, SJ., Prusiner, S., Gong, J., and Walsh, J.H. 1998. Neuropeptide Y: some viewpoints on a multifaceted peptide in thé normal and diseased nervous system. Brain Res. Rev. 26: 154-166.
28. Horvath, T.L. 1998. An alternate pathway for visual signal integration into the hypothalamo-pituitary axis: retinorecipient intergeniculate neurons project to various regions of the hypothalamus and innervate neuroendocrine cells including those producing dopamine. J. Neurosci. 18: 1546-1558.
29. Huhman, K.L., and Albers, H.E. 1994. Neuropeptide Y microinjected into the suprachiasmatic region phase shifts circadian rhythms in constant darkness. Peptides, 15: 1475-1478.
30. Huhman, K.L., Gillespie, C.F., Marvel, C.L., and Albers, H.E. 1996. Neuropeptide Y phase shifts circadian rhythms in vivo via a Y2 receptor. Neuroreport, 7: 1249-1252.
31. Jacob, N., Vuillez, P., Lakdhar-Ghazal, N., and Pevet, P. 1999. Does the intergeniculate leaflet play a role in the integration of the photoperiod by the suprachiasmatic nucleus? Brain Res. 828: 83-90.
32. Klerman, E.B., Rimmer, D.W., Dijk, D.J., Kronauer, R.E., Rizzo, J.F., 3rd, and Czeisler, C.A. 1998. Nonphotic entrainment of the human circadian pacemaker. Am. J. Physiol. 274: R991-R996.
33. Larsen, P.J., and Kristensen, P. 1998. Distribution of neuropeptide Y receptor expression in the rat suprachiasmatic nucleus. Brain Res. Mol. Brain Res. 60: 69-76.
34. Lewy, A.J., Ahmed, S., Jackson, J.M., and Sack, R.L. 1992. Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol. Int. 9: 380-392.
35. Marchant, E.G., and Mistlberger, R.E. 1996. Entrainment and phase shifting of circadian rhythms in mice by forced treadmill running. Physiol. Behav. 60: 657-663.
36. Marchant, E.G., Watson, N.V., and Mistlberger, R.E. 1997. Both neuropeptide Y and serotonin are necessary for entrainment of circadian rhythms in mice by daily treadmill running schedules. J. Neurosci. 17: 7974-7987.
37. Maywood, E.S., Smith, E., Hall, S.J., and Hastings, M.H. 1997. A thalamic contribution to arousal-induced, non-photic entrainment of the circadian clock of the Syrian hamster. Eur. J. Neurosci. 9: 1739-1747.
38. McArthur, A.J., Hunt, A.E., and Gillette, M.U. 1997. Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase C at dusk and dawn. Endocrinology, 138: 627-634.
39. Medanic, M., and Gillette, M.U. 1993. Suprachiasmatic circadian pacemaker of the rat shows two windows of sensitivity to neuropeptide Y in vitro. Brain Res. 620: 281-286.
40. Meijer, J.H., and Rietveld, W.J. 1989. Neurophysiology of the SCN circadian pacemaker in rodents. Physiol. Rev. 69: 671-707.
41. Meyer-Bernstein, E.L., and Morin, L.P. 1996. Differential serotonergic innervation of the suprachiasmatic nucleus and the intergeniculate leaflet and its role in circadian rhythm modulation. J. Neurosci. 16: 2097-2111.
42. Mintz, E.M., and Albers, H.E. 1997. Microinjection of NMDA into the SCN region mimics the phase shifting effect of light in hamsters. Brain Res. 758: 245-249.
43. Mintz, E.M., Gillespie, C.F., Marvel, C.L., Huhman, K.L., and Albers, H.E. 1997. Serotonergic regulation of circadian rhythms in Syrian hamsters. Neuroscience, 79: 563-569.
44. Moore, R.Y. 1997. Chemical neuroanatomy of the mammalian circadian system. In Handbook of experimental pharmacology. Physiology and pharmacology of biological rhythms. Edited by P.H. Redfern and B. Lammer. Springer-Verlag, Berlin, Heidelberg, pp. 79-93.
45. Morin, L.P. 1999. Serotonin and the regulation of mammalian circadian rhythmicity. Ann. Med. 31: 12-33.
46. Mrosovsky, N. 1996. Locomotor activity and non-photic influences on circadian clocks. Biol. Rev. Camb. Philos. Soc. 71: 343-372.
47. Nelson, R.J., and Zucker, I. 1981. Absence of extraocular photoreception in diurnal and nocturnal rodents exposed to direct sunlight. Comp. Biochem. Physiol. 69: 145-148.
48. Prosser, R. 1998. Neuropeptide Y blocks serotonergic phase shifts of the suprachiasmatic circadian clock in vitro. Brain Res. 808: 31-41.
49. Prosser, R., Miller, J.D., and Heller, H.C. 1990. A serotonin agonist phase-shifts the circadian clock in the suprachiasmatic nuclei in vitro. Brain Res. 534: 336-339.
50. Roenneberg, T., and Foster, R.G. 1997. Twilight times: light and the circadian system. Photochem. Photobiol. 66: 549-561.
51. Rusak, B., and Zucker, I. 1979. Neural regulation of circadian rhythms. Physiol. Rev. 59: 449-527.
52. Schak, K.M., and Harrington, M.E. 1999. Protein kinase C inhibition and activation phase advances the hamster circadian clock. Brain Res. 840: 158-161.
53. Shibata, S., and Moore, R.Y. 1993. Neuropeptide Y and optic chiasm stimulation affect suprachiasmatic nucleus circadian function in vitro. Brain Res. 615: 95-100.
54. Takatsuji, K., Senba, E., Mantyh, P.W., and Tohyama, M. 1995. A relationship between substance P receptor and retinal fibers in the rat suprachiasmatic nucleus. Brain Res. 698: 53-61.
55. Turek, F.W., and Van Reeth, O. 1989. Use of benzodiazepines to manipulate the circadian clock regulating behavioral and endocrine rhythms. Horm. Res. 31: 59-65.
56. Van Cauter, E., Moreno-Reyes, R., Akseki, E., L'Hermite-Baleriaux, M., Hirschfeld, U., Leproult, R., and Copinschi, G. 1998. Rapid phase advance of the 24-h melatonin profile response to afternoon. Am. J. Physiol. 275: E48-E54.